IRGQ-mediated autophagy in MHC class I quality control promotes tumor immune evasion.
Herhaus, L., Gestal-Mato, U., Eapen, V.V., Macinkovic, I., Bailey, H.J., Prieto-Garcia, C., Misra, M., Jacomin, A.C., Ammanath, A.V., Bagaric, I., Michaelis, J., Vollrath, J., Bhaskara, R.M., Bundgen, G., Covarrubias-Pinto, A., Husnjak, K., Zoller, J., Gikandi, A., Ribicic, S., Bopp, T., van der Heden van Noort, G.J., Langer, J.D., Weigert, A., Harper, J.W., Mancias, J.D., Dikic, I.(2024) Cell 187: 7285-7302.e29
- PubMed: 39481378 
- DOI: https://doi.org/10.1016/j.cell.2024.09.048
- Primary Citation of Related Structures:  
8Q7K - PubMed Abstract: 
The autophagy-lysosome system directs the degradation of a wide variety of cargo and is also involved in tumor progression. Here, we show that the immunity-related GTPase family Q protein (IRGQ), an uncharacterized protein to date, acts in the quality control of major histocompatibility complex class I (MHC class I) molecules. IRGQ directs misfolded MHC class I toward lysosomal degradation through its binding mode to GABARAPL2 and LC3B. In the absence of IRGQ, free MHC class I heavy chains do not only accumulate in the cell but are also transported to the cell surface, thereby promoting an immune response. Mice and human patients suffering from hepatocellular carcinoma show improved survival rates with reduced IRGQ levels due to increased reactivity of CD8+ T cells toward IRGQ knockout tumor cells. Thus, we reveal IRGQ as a regulator of MHC class I quality control, mediating tumor immune evasion.
- Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. Electronic address: lina.herhaus@gmail.com.
Organizational Affiliation: 

















